D
51
-2
FOXA
56
-7
URBN
59
-3
TRV
55
2
MMM
42
7
YUM
54
-8
TRIP
44
-3
PEG
44
-9
CMS
60
-2
AN
43
5
CMI
58
6
DG
36
-2
UPS
30
3
BDX
50
-2
CME
46
-2
ES
35
-4
STX
69
-4
WDC
72
-2
NTRS
42
-2
DIS
52
-2
D
51
-2
FOXA
56
-7
URBN
59
-3
TRV
55
2
MMM
42
7
YUM
54
-8
TRIP
44
-3
PEG
44
-9
CMS
60
-2
AN
43
5
CMI
58
6
DG
36
-2
UPS
30
3
BDX
50
-2
CME
46
-2
ES
35
-4
STX
69
-4
WDC
72
-2
NTRS
42
-2
DIS
52
-2
Financhill
Back

Microsoft Vs. Kymera Therapeutics Industry Stock Comparison

Buy
54

MSFT
Microsoft

Last Price:
$524.66
Seasonality Move:
5.8%
Sell
45

KYMR
Kymera Therapeutics

Last Price:
$40.67
Seasonality Move:
-8.02%
Buy
54
Microsoft (MSFT) is a Buy

Is Microsoft a Buy, Sell or Hold?

  • The current Microsoft [MSFT] share price is $527.75. The Score for MSFT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • MSFT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $42.97. The Score for KYMR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MSFT Stock Price Chart

What is Microsoft's stock price today?

  • The Microsoft share price today is $527.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MSFT is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $42.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

MSFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 138.79 Buy
Relative Strength Index (14 RSI): 65.57 Buy
Chaikin Money Flow: -17227732 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (497.8 - 520.28) Buy
Bollinger Bands (100): (394.41 - 499.17) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 11.42 Buy
Relative Strength Index (14 RSI): 43.1 Sell
Chaikin Money Flow: -61263 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.72 - 45.72) Sell
Bollinger Bands (100): (28.36 - 45.08) Buy

MSFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 521.63 Buy
20-day SMA: 512.48 Buy
50-day SMA: 491.68 Buy
200-day SMA: 433.96 Buy
8-day EMA: 410.25 Buy
20-day EMA: 237.26 Buy
50-day EMA: 112.01 Buy
200-day EMA: 30.55 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.89 Sell
20-day SMA: 44.85 Sell
50-day SMA: 43.76 Sell
200-day SMA: 39.33 Buy
8-day EMA: 33.79 Buy
20-day EMA: 19.63 Buy
50-day EMA: 9.28 Buy
200-day EMA: 2.53 Buy

Microsoft Earnings Growth & MSFT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.44 per share, an increase this year of $1.59 per share, and an increase next year of $2.09 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.51 per share.

Microsoft Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):